Top Markets
Coin of the day
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.

Jupiter Neurosciences, Inc.

JUNS
Clasificación en acciones #36527
Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in... Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system and causes mobility issues. Also in Phase II, JNS102 is being developed for mucopolysaccharidosis Type I, JNS107 for MELAS Syndrome, and JNS108 for mild cognitive impairment and early Alzheimer's disease. Furthermore, the company is progressing JNS109 for amyotrophic lateral sclerosis, JNS110 for traumatic brain injury and concussion, and JNS120 as a treatment for COVID-19. Founded in 2016, the company, formerly known as Jupiter Orphan Therapeutics, Inc., adopted its current name in August 2021 and is headquartered in Jupiter, Florida.
Precio por acción
$5.34
Última sincronización: 2026-08-14
Capitalización bursátil
$2.59M
Cambio (1 día)
-11.00%
Cambio (1 año)
313.95%
País
US
Comercio Jupiter Neurosciences, Inc. (JUNS)

Categoría

Precio JUNS con Capital del mercado a B
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.
JUNS
$5.34
Capitalización de mercado de Jupiter Neurosciences, Inc.(JUNS)
Capitalización bursátil: $2.59M
A fecha de August 2026, Jupiter Neurosciences, Inc. tiene una capitalización de mercado de $2.59M. Esto convierte a Jupiter Neurosciences, Inc. en la 36527th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Jupiter Neurosciences, Inc. desde 2024 hasta 2026
JUNS en comparación con los más populares 5 títulos stocks
Precio por JUNS Activo B Capital del mercado en B Resultados
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.
$11,248,311 $2.59M
$5.452T +210,642,429.22%
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.
$9,263,824 $2.59M
$4.490T +173,479,751.48%
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.
$8,587,892 $2.59M
$4.162T +160,821,839.37%
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.
$7,585,042 $2.59M
$3.676T +142,041,876.72%
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.
$5,845,143 $2.59M
$2.833T +109,459,500.50%